The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 59 | — | 20.1x | Near average | |
Growth | 19 | — | 5.6% | Below average | |
Quality | 11 | -93.4% | 7.6% | Below average | |
Safety | 52 | 0.3x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Revolution Medicines, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Revolution Medicines, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
RVMD stock saw an improvement in its consensus price target by approximately 4% over the past week, rising from $159 to $165.33, despite a decrease in the number of active analysts in the sample from 13 to 7. This adjustment reflects cautious optimism, as the stock is currently trading near the consensus average, while the median price of $174.5 indicates additional upside potential as seen by top analysts.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.